Ingalls & Snyder »

Rxo shares owned by Ingalls & Snyder

Quarter-by-quarter ownership of Rxo (RXO) shares owned by Ingalls & Snyder from 13F filings

Historical chart of Ingalls & Snyder investment in Rxo

Tip: Access up to 7 years of quarterly data

All positions including Rxo held by Ingalls & Snyder consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rxo by Ingalls & Snyder

Quarter filed Position value Share count Share price at filing
2025-09-30 $229k 15k 15.37
2025-06-30 $255k 16k 15.74

More positions owned by Ingalls & Snyder

Corcept Therapeutics Call Call Option (CORT)
Microsoft Corporation (MSFT)
Apple (AAPL)
Williams Companies (WMB)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Exxon Mobil Corporation (XOM)
Canadian Nat Res Call Call Option (CNQ)
Alphabet Cap Stk Cl A (GOOGL)
Pan American Silver Corp Can (PAAS)
JPMorgan Chase & Co. (JPM)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Procter & Gamble Company (PG)
Abbott Laboratories (ABT)

View all positions for Ingalls & Snyder

Top funds holding Rxo

Orbis Allan Gray
MFN Partners Management
BlackRock
Vanguard Group
Wellington Management Company
Finepoint Capital
Fil
State Street Corporation
Douglas Lane & Associates
Geode Capital Management
Franklin Resources
Charles Schwab Investment Management
UBS Group
Morgan Stanley
Dimensional Fund Advisors

View all funds holding Rxo